Organic Active Ingredients TRIZ Cases

Compounds inhibit GPER activity to curb estrogen-promoted cell proliferation and reduce gallstone formation.

Cyclodextrin complexes enhance oestrogen delivery to accelerate wound healing while reducing adverse effects.

Non-aqueous excipients protect the active ingredient from aqueous degradation while restoring the critical fluid layer to treat presbyopia.

TLR3 agonists activate regenerative pathways to promote hair follicle growth while preventing fibrotic scarring during wound healing.

Modular imidazopyrrolopyridine compounds target Nurr1 and Nur77 to treat cancer while minimizing harm to healthy cells.

Bifunctional PROTAC compounds recruit E3 ubiquitin ligases to mediate targeted degradation of tyrosine kinases.

A TfR-binding IDS fusion protein delivers enzyme activity across the blood-brain barrier.

Polyhexanide chewing gum uses compression forces to control release rates, resolving the trade-off between localized efficacy and formulation complexity.

Vedolizumab blocks alpha4beta7 integrins to suppress recurrent inflammation, eliminating long-term antibiotic dependency.

Chronic dantrolene administration resynchronizes calcium cycling via RyR2 modulation, addressing mechanical dyssynchrony without invasive devices.

Specific substituents on the quinoline core enhance 5-HT6 affinity while minimizing side effects from other receptors.

Replacing antibiotics with octenidine dihydrochloride in a gel formulation maintains rapid bactericidal activity while eliminating resistance development.

Monosaccharide coatings stabilize maghemite nanoparticles to bind phosphate in the gut while minimizing iron release and toxicity.

Optimized RIPK1 inhibitors resolve limited treatment options by reducing inflammation and necroptosis while maintaining selectivity.

Segmented antibody drug conjugates target tumor stroma via LRRC15 binding, overcoming treatment resistance while sparing normal cells from damage.

Azetidine compounds activate GPR119 receptors to stimulate glucose-dependent insulin secretion, lowering blood glucose without hypoglycemia.

Polymeric nanoparticles encapsulate hydrophobic modulators and disassemble in acidic endosomes to release therapeutics.

Targeting the Src/c-Abl pathway resolves ambiguity in kinase inhibitor efficacy by enhancing motor neuron survival and delaying disease progression.

Guide RNA directs endonuclease to cleave specific DNA sequences in cancer cells, avoiding damage to normal tissue.

Azaindazole compounds antagonize Wnt pathway signaling, reversing aberrant growth states and correcting genetic disorders.

Anti-CD127 agents trigger macrophage phagocytosis of CD127-positive tumor cells via Antibody Dependent Cellular Phagocytosis.

Hydroxyl adhesive groups stabilize ketamine in the matrix layer, enabling high flux without crystallization inhibitors.

Alpha-substituted DHA derivatives stabilize against oxidation and improve insulin resistance without causing weight gain or fluid retention.

Converting racemic pirlindole into diastereomeric salts enables scalable crystallization, eliminating costly large-scale chromatography.

A mammalian nutritional supplement combines turmeric, Peganum harmala, and Arum palaestinum to support physiological health.

Phosphatidylcholine entraps nitric oxide for transdermal delivery, modulating inflammatory pathways while reducing side effects from conventional therapies.

Compounds binding CD131 inhibit IL-3, IL-5, and GM-CSF signaling pathways to reduce lung inflammation.

Enzymatically cleavable linkers on pro-cyclic dinucleotides release active compounds at target sites, reducing systemic toxicity.

Developing specific crystal forms A-F resolves the trade-off between therapeutic effectiveness and chemical stability by optimizing lattice structures.

Bacterial lipopolysaccharides modulate the TLR4 signaling pathway to treat coccidiosis, reducing antibiotic resistance and intestinal damage.

A balanced dental care composition combines iodine accelerants with cannabidiol relaxants to deliver oral health benefits.

Crystallizing scutellarin aglycone into stable polymorphs overcomes poor bioavailability and instability of the crude drug.

A self-assembled complex delivers effective components using reversible ion bonding between metal ions and ligands.

Fucosyllactose oligosaccharides enhance innate immunity and demonstrate direct antiviral activity against viral infections.

IGFBP1 inhibitors target liver-derived protein to prevent musculoskeletal wasting in colorectal cancer cachexia.

Reducing glycated chitosan molecular weight below 420 kDa enables sterile filtration while preserving immune stimulation efficacy.

A sulfonamide compound inhibits voltage-gated sodium channel 1.7 with high subtype selectivity.

Isolated Bifidobacterium and Lactobacillus strains normalize intestinal microorganisms to prevent allergic diseases like rhinitis and asthma.

T-ChOS and glucosamine composition synergistically promotes tissue regeneration and collagen synthesis.

Replacing glucocorticoid steroids with ginsenoside M1 reduces severe adverse side effects while preserving renal function in IgA nephropathy patients.

Targeting NF-kB-inducing kinase disrupts signaling pathways, reducing cancer cell proliferation while managing complex regulatory trade-offs.

Sodium salt of aldose reductase inhibitor crystal form overcomes poor water solubility of the parent compound.

Polynucleotides encoding hepatocyte growth factor isoforms promote neurite outgrowth and motor neuron survival.

Pyridazinone compounds modulate Met kinase activity via structural tuning, reducing adverse effects while restoring efficacy in cancer treatments.

Saponification and solvent extraction isolate specific sterols from pumpkin seed oil, treating benign prostatic hyperplasia without hormonal side effects.

Topical sirolimus preparation treats epilepsy and autism spectrum disorder via percutaneous delivery, reducing systemic side effects.